Tandem Diabetes Care, Inc. (NASDAQ: TNDM) today announced presentation of real-world data from pediatric users of the t:slim X2™ insulin ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Corporate News FDA Management Comments

Tandem Diabetes (TNDM) Tops Q3 EPS by 11c, Revenues Beat; Raises FY19 Revenue Mid-Point GuidanceNovember 4, 2019 4:11 PM Tandem Diabetes Care Presents Positive Real-World Data from Pediatric Users of t:slim X2 Insulin Pump with Basal-IQ Technology at International ConferenceOctober 30, 2019 4:05 PM